---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-013214"
form_type: "8-K"
ticker: "CORZ"
cik: "0001839341"
company_name: "Core Scientific, Inc./tx"
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:45:35.284751+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Core Scientific restates financials for multiple periods due to improper asset capitalization, reports Q4 2025 results

## Summary
- Restatement for Non-Reliance Periods from June 30, 2024 through Sept 30, 2025 due to improper capitalization of assets committed to demolition during mining-to-HPC conversion.
- Material weakness identified in internal control over financial reporting; Marcum LLP to revise opinion to adverse on 2024 internal controls.
- Q4 2025 revenue $79.8M vs $94.9M Q4 2024; colocation revenue rose to $31.3M from $8.5M; self-mining revenue fell to $42.2M.
- Net income $216.0M vs net loss $291.1M in Q4 2024, driven by non-cash fair value gain of $330.3M on warrant and CVR liabilities.
- Capital expenditures $279.2M in Q4 2025, with $226.2M funded by CoreWeave; liquidity of $533.4M including $311.4M cash and $222.0M bitcoin.

## SEC filing metadata
- accession: 0001628280-26-013214
- form_type: 8-K
- ticker: CORZ
- cik: 0001839341
- company_name: Core Scientific, Inc./tx
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 4.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/0001628280-26-013214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/core-20260302.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-013214
- JSON: https://secwatch.observer/filing/0001628280-26-013214.json
- Plain text: https://secwatch.observer/filing/0001628280-26-013214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.